GL1X · GenesisL1 explorer

MolNFT v1 · #76455 · protein

Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with pyrazolopyrimidine 5

3QLF · Proto-oncogene tyrosine-protein kinase src: “Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with pyrazolopyrimidine 5”. X-ray diffraction, 1 ligand (PD5), 5 pockets (best druggability 0.71).…

PDB
3QLF
Type
protein
Length
507 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
PD5
Pockets
5 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein24940% helix, 16% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein25842% helix, 17% strandP00523

Ligands and binding sites

  • PD5 · 1-{4-[4-amino-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]phenyl}-3-[3-(trifluoromethyl)phenyl]urea · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17210.710.7869PD5
23960.680.8045PD5
33440.600.7740empty
41040.330.7324empty
5520.250.7313empty

Interfaces

1 interface between chains.

  • A–B · 385 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 3QLF · Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.